PubRank

Sareh Parangi

Author PubWeight™ 49.17‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 B-Raf(V600E) and thrombospondin-1 promote thyroid cancer progression. Proc Natl Acad Sci U S A 2010 2.03
2 Preoperative evaluation of thyroid nodules with 18FDG-PET/CT. Surgery 2005 1.76
3 A novel orthotopic mouse model of human anaplastic thyroid carcinoma. Thyroid 2009 1.53
4 BRAF(V600E) and microenvironment in thyroid cancer: a functional link to drive cancer progression. Cancer Res 2011 1.47
5 Carcinoid tumors in the breast. Am J Surg 2006 1.41
6 Effect of rapamycin alone and in combination with antiangiogenesis therapy in an orthotopic model of human pancreatic cancer. Clin Cancer Res 2004 1.31
7 Thrombospondin-1 modulates vascular endothelial growth factor activity at the receptor level. FASEB J 2009 1.29
8 Targeting BRAFV600E with PLX4720 displays potent antimigratory and anti-invasive activity in preclinical models of human thyroid cancer. Oncologist 2011 1.27
9 AACE/ACE disease state commentary: molecular diagnostic testing of thyroid nodules with indeterminate cytopathology. Endocr Pract 2014 1.24
10 Role of B-Raf(V600E) in differentiated thyroid cancer and preclinical validation of compounds against B-Raf(V600E). Biochim Biophys Acta 2009 1.18
11 Late intervention with anti-BRAF(V600E) therapy induces tumor regression in an orthotopic mouse model of human anaplastic thyroid cancer. Endocrinology 2011 1.13
12 Ultrasound-guided percutaneous thyroid nodule core biopsy: clinical utility in patients with prior nondiagnostic fine-needle aspirate. Thyroid 2012 1.03
13 Requirement of different signaling pathways mediated by insulin-like growth factor-I receptor for proliferation, invasion, and VPF/VEGF expression in a pancreatic carcinoma cell line. Biochem Biophys Res Commun 2003 1.02
14 Thyroidectomy with neoadjuvant PLX4720 extends survival and decreases tumor burden in an orthotopic mouse model of anaplastic thyroid cancer. Surgery 2010 1.00
15 BRAF V600E status adds incremental value to current risk classification systems in predicting papillary thyroid carcinoma recurrence. Surgery 2012 0.99
16 Hemorrhagic cholecystitis simulating gallbladder carcinoma. J Ultrasound Med 2004 0.99
17 A double hit to kill tumor and endothelial cells by TRAIL and antiangiogenic 3TSR. Cancer Res 2009 0.99
18 The BRAFV600E mutation: what is it really orchestrating in thyroid cancer? Oncotarget 2010 0.98
19 Adeno-associated virus-mediated antiangiogenic gene therapy with thrombospondin-1 type 1 repeats and endostatin. Clin Cancer Res 2007 0.97
20 Clinical and cytological features predictive of malignancy in thyroid follicular neoplasms. Thyroid 2010 0.96
21 Best cases from the AFIP: paraganglioma of the organs of Zuckerkandl. Radiographics 2003 0.96
22 The thyroid incidentaloma: an increasingly frequent consequence of radiologic imaging. Semin Ultrasound CT MR 2005 0.95
23 The vascular permeabilizing factors histamine and serotonin induce angiogenesis through TR3/Nur77 and subsequently truncate it through thrombospondin-1. Blood 2013 0.93
24 Antiangiogenic treatment with three thrombospondin-1 type 1 repeats versus gemcitabine in an orthotopic human pancreatic cancer model. Clin Cancer Res 2005 0.93
25 Antiangiogenic treatment with the three thrombospondin-1 type 1 repeats recombinant protein in an orthotopic human pancreatic cancer model. Clin Cancer Res 2005 0.92
26 Thyroid surgery in octogenarians is associated with higher complication rates. Surgery 2009 0.92
27 Management of thyroid nodules with atypical cytology on fine-needle aspiration biopsy. Ann Surg Oncol 2012 0.91
28 Summary statement: utility of molecular marker testing in thyroid cancer. Surgery 2010 0.90
29 Hyalinizing trabecular adenoma--an uncommon thyroid tumor frequently misdiagnosed as papillary or medullary thyroid carcinoma. Am J Surg 2007 0.89
30 Accuracy of 4-dimensional computed tomography in poorly localized patients with primary hyperparathyroidism. Surgery 2010 0.88
31 Management of thyroid incidentalomas. Surg Clin North Am 2004 0.88
32 Thyroid incidentalomas: a new epidemic. Curr Surg 2004 0.88
33 Resident/fellow assistance in the operating room for endocrine surgery in the era of fellowships. Surgery 2010 0.85
34 Continuous administration of the three thrombospondin-1 type 1 repeats recombinant protein improves the potency of therapy in an orthotopic human pancreatic cancer model. Cancer Lett 2006 0.85
35 Angiogenesis in benign and malignant thyroid disease. Thyroid 2005 0.84
36 Thyroid lobe ablation with radioactive iodine as an alternative to completion thyroidectomy after hemithyroidectomy in patients with follicular thyroid carcinoma: long-term follow-up. Thyroid 2012 0.82
37 Medical and surgical risks in thyroid surgery: lessons from the NSQIP. Ann Surg Oncol 2011 0.82
38 Surgical implications of B-RafV600E mutation in fine-needle aspiration of thyroid nodules. Am J Surg 2010 0.82
39 Bilaterality in papillary thyroid carcinoma: does it influence prognosis? Ann Surg Oncol 2012 0.81
40 Potential role of 5-aza-2'-deoxycytidine induced MAGE-A4 expression in immunotherapy for anaplastic thyroid cancer. Surgery 2013 0.81
41 Multiple signaling is involved in endostatin-mediated apoptosis in ECV 304 endothelial cells. Front Biosci 2005 0.80
42 Diagnostic yield of nondiagnostic thyroid nodules is not altered by timing of repeat biopsy. Thyroid 2012 0.80
43 Preoperative basal calcitonin and tumor stage correlate with postoperative calcitonin normalization in patients undergoing initial surgical management of medullary thyroid carcinoma. Surgery 2011 0.78
44 The next generation of orthotopic thyroid cancer models: immunocompetent orthotopic mouse models of BRAF V600E-positive papillary and anaplastic thyroid carcinoma. Thyroid 2014 0.78
45 Case records of the Massachusetts General Hospital: Case 38-2010: a 13-year-old girl with an enlarging neck mass. N Engl J Med 2010 0.77
46 The Bethesda System for Reporting Thyroid Cytopathology: Proposed Modifications and Updates for the Second Edition from an International Panel. Acta Cytol 2016 0.77
47 Overcoming obstacles to setting up office-based ultrasound for evaluation of thyroid and parathyroid diseases. Laryngoscope 2011 0.77
48 A potential role for immunotherapy in thyroid cancer by enhancing NY-ESO-1 cancer antigen expression. Thyroid 2014 0.77
49 When initial postexcision PTH level does not fall appropriately during parathyroidectomy: what to do next? World J Surg 2009 0.76
50 Laparoscopic adrenalectomy for pheochromocytoma. Curr Surg 2004 0.76
51 Quantification of vascular endothelial cell apoptosis in vivo. Methods Enzymol 2008 0.75
52 The gene expression and activity of calpains and the muscle wasting-associated ubiquitin ligases, atrogin-1 and MuRF1, are not altered in patients with primary hyperparathyroidism. Int J Mol Med 2006 0.75
53 Surgery for Graves' disease: a 25-year perspective. Am J Surg 2013 0.75
54 Case records of the Massachusetts General Hospital. Case 10-2015. A 15-year-old girl with Graves’ disease and psychotic symptoms. N Engl J Med 2015 0.75
55 Parathyroid carcinoma and neurofibromatosis. Surgery 2008 0.75
56 Surgical drains can be safely avoided in lateral neck dissections for papillary thyroid cancer. Am J Surg 2010 0.75
57 Partial thyroidectomy: illustrated reflections for surgical residents. Curr Surg 2005 0.75
58 Image of the month: acute and chronic cholecystitis with abscess formation. Arch Surg 2006 0.75
59 Image of the month. Enterolithotomy. Arch Surg 2006 0.75